We are live on ! Find out more
MBII

Marrone Bio Innovations, Inc.
MBII

Delisted

MBII was delisted on the 12th of July, 2022.

Back to rankings

58 hedge funds and large institutions have $62.3M invested in Marrone Bio Innovations, Inc. in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 21 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

6% more capital invested

Capital invested by funds: $59M → $62.3M (+$3.31M)

4% more funds holding

Funds holding: 56 → 58 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

43% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 21

Holders
58
Holders Change
+2
Holders Change %
+3.57%
% of All Funds
1.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
12
Reduced
21
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AAP
Ardsley Advisory Partners
Connecticut
+$417K
2
WRF
Waddell & Reed Financial
Kansas
+$375K
3
Northern Trust
Northern Trust
Illinois
+$210K
4
Russell Investments Group
Russell Investments Group
United Kingdom
+$166K
5
TRCT
Tower Research Capital (TRC)
New York
+$56.6K

Top Sellers

Rank Fund Capital Flow
1
Primecap Management
Primecap Management
California
-$188K
2
BlackRock
BlackRock
New York
-$60.4K
3
Citadel Advisors
Citadel Advisors
Florida
-$44.4K
4
SG Americas Securities
SG Americas Securities
New York
-$43K
5
SIM
Spark Investment Management
New York
-$39K
Name Holding Trade Value Shares
Change 		Change in
Stake
FAIM
26
Financial Advocates Investment Management
Washington
$38K +$37.6K +30,925 New
Barclays
27
Barclays
United Kingdom
$37K -$7.47K -6,142 -17%
VOYA Investment Management
28
VOYA Investment Management
Georgia
$31K – – –
IAM
29
ICM Asset Management
Washington
$26K – – –
New York State Common Retirement Fund
30
New York State Common Retirement Fund
New York
$26K – – –
Victory Capital Management
31
Victory Capital Management
Texas
$24K -$1.65K -1,354 -6%
UBS Group
32
UBS Group
Switzerland
$19K -$9.54K -7,848 -34%
PP
33
Paloma Partners
Connecticut
$19K +$18.5K +15,203 New
Citadel Advisors
34
Citadel Advisors
Florida
$17K -$44.4K -36,495 -72%
Morgan Stanley
35
Morgan Stanley
New York
$17K -$18.9K -15,514 -52%
BNP Paribas Financial Markets
36
BNP Paribas Financial Markets
France
$15.7K +$11.7K +9,590 +295%
RJFSA
37
Raymond James Financial Services Advisors
Florida
$15K – – –
AF
38
Allworth Financial
California
$14K – – –
HF
39
HRT Financial
New York
$14K +$14.3K +11,759 New
Principal Financial Group
40
Principal Financial Group
Iowa
$12K -$866 -712 -7%
AB
41
Amalgamated Bank
New York
$12K -$40 -33 -0.3%
AWM
42
Avior Wealth Management
Nebraska
$12K – – –
Legal & General Group
43
Legal & General Group
United Kingdom
$9K -$3.12K -2,564 -26%
Bank of America
44
Bank of America
North Carolina
$9K -$3.02K -2,485 -25%
AIP
45
Ameritas Investment Partners
Nebraska
$6K – – –
Citigroup
46
Citigroup
New York
$4K -$5.93K -4,875 -60%
Bank of Montreal
47
Bank of Montreal
Ontario, Canada
$4K -$2.67K -2,196 -41%
PAM
48
Panagora Asset Management
Massachusetts
$4K – – –
CFA
49
Carroll Financial Associates
North Carolina
$2K – – –
MAM
50
Meeder Asset Management
Ohio
$1K -$323 -266 -20%
1
2
3

MBII Hedge Fund Activity: Q3 2020 in Review

58 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q3 2020, worth a combined $62.3M — up 5.6% from $59M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new MBII positions and 4 closed out — a net gain of 2 holders — while 12 added to existing stakes and 21 trimmed.

The largest buyer was Ardsley Advisory Partners, adding an estimated $417K. The largest seller was Primecap Management, cutting an estimated $188K.

  • 58 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q3 2020, up from 56 in Q2 2020.
  • Funds reported $62.3M of Marrone Bio Innovations, Inc. stock for Q3 2020, up 5.6% quarter-over-quarter.
  • 6 funds opened new Marrone Bio Innovations, Inc. positions in Q3 2020 and 4 closed out, a net change of +2 holders.
  • The largest Marrone Bio Innovations, Inc. buyer in Q3 2020 was Ardsley Advisory Partners, an estimated $417K added.
  • The largest Marrone Bio Innovations, Inc. seller in Q3 2020 was Primecap Management, an estimated $188K sold.

Based on aggregated 13F filings for Q3 2020.